Patents by Inventor Sivan COHEN

Sivan COHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE
    Publication number: 20230279067
    Abstract: The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
    Type: Application
    Filed: November 21, 2022
    Publication date: September 7, 2023
    Applicant: Genentech, Inc.
    Inventors: Yichin LIU, Christine Carine MOUSSION, Travis William BAINBRIDGE, lraj HOSSEINI, Gregory Alan LAZAR, Sivan COHEN, Christopher Charles KEMBALL, Jill M. SCHARTNER
  • T CELL-BASED METHODS FOR PREDICTING POLYPEPTIDE IMMUNOGENICITY
    Publication number: 20230184747
    Abstract: The presently disclosed subject matter provides methods for determining the propensity of a composition, e.g., a composition comprising an antibody or a fragment thereof, to elicit production of anti-drug antibodies (ADAs) and kits for performing such methods.
    Type: Application
    Filed: February 2, 2023
    Publication date: June 15, 2023
    Applicant: GENENTECH, INC.
    Inventors: Shan Chung, Sivan Cohen
  • FLT3 ligand fusion proteins and methods of use
    Patent number: 11542308
    Abstract: The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: January 3, 2023
    Assignee: Genentech, Inc.
    Inventors: Yichin Liu, Christine Carine Moussion, Travis William Bainbridge, Iraj Hosseini, Gregory Alan Lazar, Sivan Cohen, Christopher Charles Kemball, Jill M. Schartner
  • FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE
    Publication number: 20220289803
    Abstract: The invention provides an effectoriess immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 15, 2022
    Applicant: Genentech, Inc.
    Inventors: Yichin LIU, Christine Carine MOUSSION, Travis William BAINBRIDGE, Iraj HOSSEINI, Gregory Alan LAZAR, Sivan COHEN, Christopher Charles KEMBALL, Jill M. SCHARTNER